Citius Oncology INC
+$2.4M
Net Activity
Data as of: 2026-03-31
Institutions Holding
14
Popularity Rank
#9043
Avg Weight
0.01%
Total Value
$8.8M
14 institutions currently hold CTOR, with 8 net buyers and 7 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
7
Net Buying Institutions
8
Top 5 by Value
Across its top 14 institutional holders, CTOR's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 25/100).
+$8.4M
Total Buy Value
$228.3K
Total Sell Value
8
Net Buyers
7
Net Sellers
CTOR does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CTOR
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
No Form 8-K filings for this ticker
17331Y109
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,153
Total reported value
$2.1T
3246 13F institutions increased their position this quarter
Institutions Holding
5,960
Total reported value
$1.5T
3030 13F institutions increased their position this quarter
Institutions Holding
5,769
Total reported value
$3.0T
2744 13F institutions increased their position this quarter
Access CTOR's institutional ownership data programmatically:
REST API
curl https://alphasmo.com/api/v1/market/stock/CTORCLI
npx alphasmo stocks get CTORFull API & MCP documentation →